SEARCH

SEARCH BY CITATION

References

  • Ageno, W., Prandoni, P., Romauldi, E., Chirarduzzi, A., Dentali, F., Pesavento, R., Crowther, M. & Venco, A. (2006) The metabolic syndrome and the risk of venous thrombosis: a case-control study. Journal of Thrombosis and Haemostasis, 4, 19141918.
  • Ageno, W., Becattini, C., Brighton, T., Selby, R. & Kamphuisen, P.W. (2007) Cardiovascular risk factors and venous thromboembolism: a meta-analysis. Journal of Thrombosis and Haemostasis, 5(Suppl. 2), O-W-059.
  • Agnelli, G. & Becattini, C. (2006) Venous thromboembolism and atherosclerosis: common denominators or different diseases? Journal of Thrombosis and Haemostasis, 4, 18861890.
  • Albers, G.W., Amarenco, P., Easton, J.D., Sacco, R.L. & Teal, P. (2004) Antithrombotic and thrombolytic therapy for ischemic stroke. Chest, 126, 483s512s.
  • Antithrombotic Trialists’ Collaboration. (2002) Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. British Medical Journal, 324, 7186.
  • Becattini, C., Agnelli, G., Prandoni, P., Silingardi, M., Salvi, R., Taliani, M.R., Poggio, R., Imberti, D., Ageno, W., Pogliani, E., Porro, F. & Casazza, F. (2005) A prospective study on cardiovascular events after acute pulmonary embolism. European Heart Journal, 26, 7783.
  • Bloemenkamp, K.M.M. & Helmerhorst, F.M. (2007) The oral contraceptive pill, mechanisms of vascular risk, and practical prescribing strategies for women with thrombotic problems. In: Women’s Vascular Health (ed. by I.A.Greer, J.Ginsberg & C.D.Forbes), pp. 423435. Arnold, London.
  • Blood Pressure Lowering Treatment Trialists’ Collaborators. (2003) Effects of different blood-pressure-lowering regimens on major cardiovascular events. Lancet, 362, 15271535.
  • Bova, C., Marchiori, A., Noto, A., Rossi, V., Daniele, F., Santoro, C., Ricchio, R., De Lorenzo, R., Umbaca, R. & Prandoni, P. (2006) Incidence of arterial cardiovascular events in patients with idiopathic venous thromboembolism. A retrospective cohort study. Thrombosis and Haemostasis, 96, 132136.
  • Castaman, G., Tosetto, A., Simioni, M., Ruggeri, M., Madeo, D. & Rodeghiero, F. (2001) Phenotypic APC resistance in carriers of the A20210 prothrombin mutation is associated with an increased risk of venous thrombosis. Thrombosis and Haemostasis, 86, 804808.
  • Cholesterol Trialists’ Treatment Collaborators. (2005) Efficacy and safety of cholesterol lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet, 366, 12691278.
  • Cuzick, J., Powles, T., Veronesi, U., Forbes, J., Edwards, R., Ashley, S. & Boyle, P. (2003) Overview of the main outcomes in breast-cancer prevention trials. Lancet, 361, 296300.
  • Doll, R., Peto, R., Boreham, J. & Sutherland, I. (2004) Mortality in relation to smoking. British Medical Journal, 328, 15191528.
  • Eliasson, A., Bergqvist, D., Bjorck, M., Acosta, S., Sternby, N.H. & Ogren, M. (2006) Prevalence and risk of venous thromboembolism in patients with verified arterial thrombosis: a population study based on 23,796 consecutive autopsies. Journal of Thrombosis and Haemostasis, 4, 18971902.
  • Emberson, J.R., Whincup, P.H., Morris, R.W., Walker, M., Lowe, G.D.O. & Rumley, A. (2004) Extent of regression dilution for established and novel coronary risk factors: results from the British Regional Heart Study. European Journal of Cardiovascular Prevention and Rehabilitation, 11, 125134.
  • Fowkes, F.G.R., Lowe, G.D.O., Housley, E., Rattray, A., Rumley, A., Elton, R.A., MacGregor, I.R. & Dawes, J. (1993) Cross-linked fibrin degradation products, progression of peripheral arterial disease, and risk of coronary heart disease. Lancet, 342, 8486.
  • Freeman, D.J., Robertson, M., Ford, I., Gaw, A., Greer, I.A., Stott, D.J. & Lowe, G.D. (2007) Risk factors for the development of incident venous thrombotic events in the prospective study of pravastatin in the elderly at risk (PROSPER). Platelets, 18, Suppl. 118 (abstract).
  • Goldhaber, S.Z., Savage, D.D., Garrison, R.J., Castelli, W.P., Kannel, W.B., McNamara, P.M., Gherardi, G. & Feinleib, M. (1983) Risk factors for pulmonary embolism. The Framingham study. American Journal of Medicine, 74, 10231028.
  • Goldhaber, S.Z., Grodstein, F., Stampfer, M.J., Manson, J.E., Colditz, G.A., Speizer, F.E., Willett, W.C. & Hennekens, C.H. (1997) A prospective study of risk factors for pulmonary embolism in women. The Journal of the American Medical Association, 277, 642645.
  • Gordon, T. & Kannel, W.B. (1972) Predisposition to atherosclerosis in the head, heart and legs. The Framingham Study. The Journal of the American Medical Association, 221, 661.
  • Greaves, M., Cohen, H., Machin, S.J. & Mackie, I., on behalf of the Haemostasis and Thrombosis Task Force of the British Committee for Standardisation in Haematology. (2002) Guidelines on the investigation and management of the antiphospholipid syndrome. British Journal of Haematology, 109, 704715.
  • Greer, I.A., Ginsberg, J. & Forbes, C.D. (eds). (2007) Women’s Vascular Health. Arnold, London.
  • Grundy, S.M., Cleeman, J.I., Daniels, S.R., Donato, K.A., Eckel, R.H., Franklin, B.A., Gordon, D.J., Krauss, R.M., Savage, P.J., Smith, S.C., Spertus, J.A. & Costa, F. (2005) Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation, 112, 27352752.
  • Van Der Hagen, P.B., Folsom, A.R. & Jenny, N.S. (2006) Subclinical atherosclerosis and the risk of future venous thrombosis in the Cardiovascular Health Study. Journal of Thrombosis and Haemostasis, 4, 19031908.
  • Hansson, P.O., Eriksson, H., Welin, L., Svardsudd, K. & Wilhelmsen, L. (1999) Smoking and abdominal obestiy. Risk factors for VTE among middle-aged men. “The study of men born in 1913”. Archives of Internal Medicine, 159, 18861890.
  • Heit, J.A. (2005) Venous thromboembolism: disease burden, outcomes and risk factors. Journal of Thrombosis and Haemostasis, 8, 16111617.
  • Heit, J.A., Silverstein, M.D., Mohr, D.N., Petterson, T.M., O’Fallon, W.M. & Melton, III, L.J. (2000) Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Archives of Internal Medicine, 160, 809815.
  • Hong, C., Zhu, F., Du, D., Pilgram, T.K., Sicard, G.A. & Bae, K.T. (2005) Coronary artery calcification and risk factors for atherosclerosis in patients with venous thromboembolism. Atherosclerosis, 183, 169174.
  • Hovens, M.M.C., Snoep, J.D., Tamsma, J.T. & Huisman, M.V. (2006) Aspirin in the prevention and treatment of venous thromboembolism. Journal of Thrombosis and Haemostasis, 4, 14701475.
  • Hume, M., Sevitt, S. & Thomas, D.P. (1970) Venous Thrombosis and Pulmonary Embolism. Harvard University Press, Cambridge, MA.
  • Joint British Societies. (2005) JBS-2: Joint British Societies’ guidelines on prevention of cardiovascular disease in clinical practice. British Cardiac Society, British Hypertension Society, Diabetes UK, HEART UK, Primary Care Cardiovascular Society Stroke Association. Heart, 92(Suppl. 5), 152.
  • Juhan-Vague, I., Alessi, M.C. & Orange, P.E. (2000) Hypofibrinolysis and increased PAI-1 are linked to atherothrombosis via insulin resistance and obesity. Annals of Medicine, 32, 7884.
  • Kim, R.J. & Becker, R.C. (2003) Association between factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations and events of the arterial circulatory system: a meta-analysis of published studies. American Heart Journal, 146, 948957.
  • Kujovich, J.L. (2004) Hormones and pregnancy: thromboembolic risks for women. British Journal of Haematology, 126, 443454.
  • Kyrle, P.A. & Eichinger, S. (2005) Deep vein thrombosis. Lancet, 365, 11631174.
  • Levine, M.N., Lee, A.Y. & Kakkar, A.K. (2003) From Trousseau to targeted therapy; new insights and innovations in thrombosis and cancer. Journal of Thrombosis and Haemostasis, 1, 14561463.
  • Libby, P., Ridker, P.M. & Maseri, A. (2002) Inflammation and atherosclerosis. Circulation, 105, 11351143.
  • Lijfering, W.M., Ten Kate, M.K., Sprenger, H.G. & Van Der Meer, J. (2006) Absolute risk of venous and arterial thrombosis in HIV-infected patients and effects of combination antiretroviral therapy. Journal of Thrombosis and Haemostasis, 4, 19281930.
  • Lowe, G.D.O. (2006a) Arterial disease and venous thrombosis: are they related, and if so, what should we do about it? Journal of Thrombosis and Haemostasis, 4, 18821885.
  • Lowe, G.D.O. (2006b) Can haematological tests predict cardiovascular risk? The 2005 Kettle Lecture. British Journal of Haematology, 133, 232250.
  • Lowe, G.D.O. (2007) Update on the cardiovascular risks of hormone replacement therapy. Women’s Health, 3, 8797.
  • Lowe, G.D.O., Rumley, A., Woodward, M., Morrison, C.E., Philippou, H., Lane, D.A. & Tunstall-Pedoe, H. (1997) Epidemiology of coagulation factors, inhibitors and activation markers: the Third Glasgow MONICA Survey. I. Illustrative reference ranges by age, sex and hormone use. British Journal of Haematology, 97, 775784.
  • Medical Research Council’s General Practice Framework. (1998) Thrombosis prevention trial. Lancet, 351, 233241.
  • Nieto, F.J. (1999) Cardiovascular disease and risk factor epidemiology: a look back at the epidemic of the 20th century. American Journal of Public Health, 89, 292294.
  • Pomp, E.R., Rosendaal, F.R. & Doggen, C.J.M. (2007) Smoking Increases the Risk of Venous Thrombosis. 2007 International Society on Thrombosis and Haemostasis Abstracts (P-T-546). XXIst Congress of the International Society on Thrombosis and Haemostasis. Available at http://isth2007.abstractsondemand.com/ [Accessed 31 December 2007].
  • Prandoni, P., Bilora, F., Marchiori, A., Bernardi, E., Petrobelli, F., Lensing, A.W., Prins, M.H. & Girolami, A. (2003) An association between atherosclerosis and venous thrombosis. New England Journal of Medicine, 348, 14351441.
  • Prandoni, P., Ghirarduzzi, A., Prins, M.H., Pengo, V., Davidson, B.L., Sorensen, H.T., Pesavento, R., Iotti, M., Casiglia, E., Ileceto, S., Pagnana, A. & Lensing, A.W. (2006) Venous thromboembolism and the risk of subsequent symptomatic atherosclerosis. Journal of Thrombosis and Haemostasis, 4, 18911896.
  • Prandoni, P., Villalta, S., Tormene, D., Spiezia, L. & Pesavento, R. (2007) Immobilisation resulting from chronic medical diseases: a new risk factor for recurrent venous thromboembolism in anticoagulated patients. Journal of Thrombosis and Haemostasis, 5, 17861787.
  • Ray, J.G. (2003) Dyslipidemia, statins and venous thromboembolism: a potential risk factor and a potential treatment. Current Opinion in Pulmonary Medicine, 9, 378384.
  • Reich, L., Folsom, A.R., Key, N.S., Boland, L.L., Heckbert, S.R., Rosamond, W.D. & Cushman, M. (2006) Prospective study of subclinical atherosclerosis as a risk factor for venous thromboembolism. Journal of Thrombosis and Haemostasis, 4, 19091913.
  • Robertson, L., Wu, O., Langhorne, P., Twaddle, S., Clark, P., Lowe, G.D., Walker, I.D., Greaves, M., Brenkel, I., Regan, L. & Greer, I.A., The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) Study. (2006) Thrombophilia in pregnancy: a systematic review. British Journal of Haematology, 132, 171196.
  • Rosendaal, F.R. (1999) Venous thrombosis: a multicausal disease. Lancet, 353, 11671173.
  • Rosendaal, F.R., Van Hylckama Vlieg, A., Tanis, B.C. & Helmerhorst, M. (2003) Estrogens, progestogens and thrombosis. Journal of Thrombosis and Haemostasis, 1, 13711380.
  • Ross, R. (1999) Atherosclerosis – an inflammatory disease. New England Journal of Medicine, 340, 115126.
  • Rumley, A., Emberson, J.R., Wannamethee, S.G., Lennon, L., Whincup, P.H. & Lowe, G.D. (2006) Effects of older age on fibrin D-dimer, C-reactive protein and other hemostatic and inflammatory variables in men aged 60-79 years. Journal of Thrombosis and Haemostasis, 4, 982987.
  • Schulman, S., Lindmarker, P., Holmstrom, M., Larfars, G., Carlsson, A., Nicol, P., Svensson, E., Ljungberg, B., Viering, S., Nordlander, S., Leijd, B., Jahed, K., Hjorth, M., Linder, O. & Beckman, M. (2006) Post-thrombotic syndrome, recurrence, and death 10 years after the first episode of venous thromboembolism treated with warfarin for 6 weeks or 6 months. Journal of Thrombosis and Haemostasis, 4, 734742.
  • Scottish Intercollegiate Guidelines’ Network (SIGN). (2007a) Stable Angina. SIGN, Edinburgh ( http://www.sign.ac.uk/pdf/sign96.pdf). [Accessed 31 December 2007].
  • Scottish Intercollegiate Guidelines Network (SIGN). (2007b) Risk Estimation and the Prevention of Cardiovascular Disease. SIGN, Edinburgh ( http://www.sign.ac.uk/pdf/sign97.pdf). [Accessed 31 December 2007].
  • Smeeth, L., Thomas, S.L., Hall, A.J., Hubbard, R., Farrington, P. & Vallance, P. (2004) Risk of myocardial infarction and stroke after acute infection or vaccination. New England Journal of Medicine, 351, 26112618.
  • Smeeth, L., Cook, C., Thomas, S., Hall, A.J., Hubbard, R. & Vallance, P. (2006) Risk of deep vein thrombosis and pulmonary embolism after acute infection in a community setting. Lancet, 367, 10751079.
  • Smith, A., Patterson, C., Yarnell, J., Rumley, A., Ben-Shlomo, Y. & Lowe, G. (2005) Which hemostatic markers add to the predictive value of conventional risk factors for coronary heart disease and ischemic stroke? The Caerphilly Study. Circulation, 112, 30803087.
  • Sorensen, H.T., Horvath-Puho, E., Pedersen, L., Baron, J.A. & Prandoni, P. (2007) Venous thromboembolism and subsequent hospitalization due to acute arterial cardiovascular events – a 20 year cohort study. Lancet, 370, 17731779.
  • Squizzato, A., Romualdi, E. & Ageno, W. (2006) Why should statins prevent venous thromboembolism? A systematic literature search and a call for action. Journal of Thrombosis and Haemostasis, 4, 19251927.
  • Tsai, A., Cushman, M., Rosamond, W., Heckbert, S., Polak, J.F. & Folsom, A.R. (2002) Cardiovascular risk factors and VTE incidence. Archives of Internal Medicine, 162, 11821189.
  • Tzoulaki, I., Murray, G.D., Price, J.F., Smith, F.B., Lee, A.J., Rumley, A., Lowe, G.D. & Fowkes, F.G. (2006) Hemostatic factors, inflammatory markers and progressive peripheral atherosclerosis: the Edinburgh Artery Study. American Journal of Epidemiology, 163, 334341.
  • Wannamethee, S.G., Lowe, G.D.O., Whincup, P.H., Rumley, A., Walker, M. & Lennon, L. (2002) Physical activity and hemostatic and inflammatory variables in elderly men. Circulation, 105, 17851790.
  • Wannamethee, S.G., Lowe, G.D.O., Shaper, A.G., Rumley, A., Lennon, L. & Whincup, P.H. (2004) Insulin resistance, haemostatic and inflammatory markers and coronary heart disease risk factors in type 2 diabetes with and without coronary heart disease. Diabetologia, 47, 15571565.
  • Wannamethee, S.G., Lowe, G.D.O., Shaper, A.G., Rumley, A., Lennon, L. & Whincup, P.H. (2005a) The metabolic syndrome and insulin resistance: relationship to haemostatic and inflammatory markers in older non-diabetic men. Atherosclerosis, 181, 101108.
  • Wannamethee, S.G., Lowe, G.D.O., Shaper, A.G., Rumley, A., Lennon, L. & Whincup, P.H. (2005b) Association between cigarette smoking, pipe/cigar smoking, and smoking cessation, and haemostatic and inflammatory markers for cardiovascular disease. European Heart Journal, 26, 17651773.
  • Woodward, M., Lowe, G.D.O., Rumley, A., Tunstall-Pedoe, H., Philippou, H., Lane, D.A. & Morrison, C.E. (1997) Epidemiology of coagulation factors, inhibitors and activation markers: the Third Glasgow MONICA Survey. II. Relationships to cardiovascular risk factors and prevalent cardiovascular disease. British Journal of Haematology, 97, 785797.
  • World Health Organisation. (2004) Improving Access to Quality Care in Family Planning. Medical Eligibility Criteria for Contraceptive Use, 3rd edn. WHO, Geneva.
  • Wu, O., Clark, P., Lowe, G.D.O., Walker, I.D. & Greer, I.A. (2005a) Thrombophilia and venous thromboembolism after total hip or knee replacement surgery: a systematic review. Journal of Thrombosis and Haemostasis, 2005, 3.
  • Wu, O., Robertson, L., Langhorne, P., Twaddle, S., Lowe, G.D.O., Clark, P., Greaves, M., Walker, I.D., Brenkel, I., Regan, L. & Greer, I.A. (2005b) Oral contraceptives, hormone replacement therapy, thrombophilias and risk of venous thromboembolism: a systematic review. Thrombosis and Haemostasis, 94, 1725.
  • Wu, O., Robertson, L., Twaddle, S., Lowe, G., Clark, P., Walker, I., Brenkel, I., Greaves, M., Langhorne, P., Regan, L. & Greer, I. (2005c) Screening for thrombophilia in high-risk situations: a meta-analysis and cost-effectiveness analysis. British Journal of Haematology, 131, 8090.
  • Wu, O., Robertson, L., Twaddle, S., Lowe, G.D., Clark, P., Greaves, M., Walker, I.D., Langhorne, P., Brenkel, I., Regan, L. & Greer, I. (2006) Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessement of Thrombophilia Screening (TREATS) study. Health Technology Assessment (Winchester, England), 10, 1110.
  • Ye, Z., Liu, E.H.C., Higgins, J.P.T., Keavney, B.D., Lowe, G.D.O., Collins, R. & Danesh, J. (2006) Seven haemostatic polymorphisms and coronary disease: a meta analysis comprising 66155 cases and 91307 controls. Lancet, 367, 651658.
  • Yusuf, S., Hawken, S., Ounpuu, S., Dans, T., Avezum, A., Lanas, F., McQueen, M., Budaj, A., Pais, P., Varigos, J. & Lisheng, L., on behalf of the INTERHEART Study Investigators. (2004) Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART Study): case-control study. Lancet, 364, 937952.